We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Radcal IBA  Group

Download Mobile App




Older Adults Accept Dementia Telephone Screening

By HospiMedica International staff writers
Posted on 10 May 2015
Nearly two-thirds of older adults in the United States are willing to undergo telephone screening for dementia, according to a new study.

Researchers from Indiana University (Bloomington, IN, USA) and the Regenstrief Institute (Indianapolis, IN, USA) conducted a phone survey of 400 older primary care patients on their perceptions of the risks and benefits of dementia screening, and to measure the association between attitudes and actual screening behaviors. More...
Eligible patients completed the Perceptions Regarding Investigational Screening for Memory in Primary Care (PRISM-PC) questionnaire, and were then asked to undergo dementia screening by telephone.

The results pointed to a 63.7% willingness to be screened by phone for dementia, regardless of sex, age, or race. The two most significant predictors of willingness to be screened by phone were belief in benefits of early knowledge of cognitive decline, and having a friend or relative with Alzheimer's disease (AD). Participants who refused screening were also less likely to agree on screening for other conditions, such as depression and cancer. The study was published on April 6, 2015, in the Journal of Aging Research.

“Despite rising incidence rates of Alzheimer's and other dementias, many individuals with cognitive impairment are not screened. They go unrecognized and thus never receive evaluation or diagnosis,” said lead author Nicole Fowler, PhD, and colleagues of the Indiana University Center for Aging Research. “Understanding patients' attitude about the risk and benefits of early identification of dementia is vital as we evaluate potential screening barriers and facilitators.”

Dementia is an overall term for the wide range of symptoms associated with a decline in memory or other cognitive skills severe enough to reduce a person's ability to perform everyday activities. The incidence of dementia is growing globally, with a new patient being diagnosed approximately every 7 seconds. It is estimated that by 2050 there will be 11–19 million people in the USA alone living with dementia, of which AD, a progressive condition, is the most common form.

Related Links:

Indiana University
Regenstrief Institute



Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
12-Channel ECG
CM1200B
New
Dual-Screen Medical Display
C822W
New
Anesthetic Gas Measurement Module
Scio Four
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The engine-free, nonlinear, flexible, micro-robotic platform leverages AI to optimize GBM treatment (Photo courtesy of Symphony Robotics)

First-Ever MRI-Steerable Micro-Robotics to Revolutionize Glioblastoma Treatment

Glioblastoma Multiforme (GBM) is one of the most aggressive and difficult-to-treat brain cancers. Traditional surgical procedures, such as craniotomies, involve significant invasiveness, requiring large... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.